Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Anna Saucier"'
Autor:
Kevin Charles Miller, Patrick Connor Johnson, Jeremy S. Abramson, Jacob D. Soumerai, Andrew J. Yee, Andrew R. Branagan, Elizabeth K. O’Donnell, Anna Saucier, Caron A. Jacobson, Matthew J. Frigault, Noopur S. Raje
Publikováno v:
Blood Cancer Journal, Vol 12, Iss 10, Pp 1-12 (2022)
Abstract Chimeric antigen receptor T cells (CAR T) are groundbreaking therapies but may cause significant toxicities including cytokine release syndrome (CRS), immune effector cell-associated neurotoxicity syndrome (ICANS), and cytopenias. Granulocyt
Externí odkaz:
https://doaj.org/article/3228817cf75c47368f94792a61f6aa4d
Autor:
Jennifer L. Crombie, Caron A. Jacobson, Robert Redd, Geoffrey Shouse, Alex F. Herrera, Victor A. Chow, Jordan Gauthier, Erin Mullane, Kirk Cahill, Justin Kline, Jason Romancik, Jonathon B. Cohen, Anna Saucier, Roch Houot, Philippe Armand, Brian Hess
Publikováno v:
Haematologica, Vol 108, Iss 12 (2023)
Externí odkaz:
https://doaj.org/article/5acdfcb9d33441d58498adc67547a25c
Autor:
Julie Porter, Cindy Albert, Haesook T. Kim, Sarah Nikiforow, Corey Cutler, Mahasweta Gooptu, Clifton C. Mo, Katie Maurer, Rizwan Romee, Utkarsh Acharya, Joseph H. Antin, Caron A. Jacobson, John Koreth, Catherine J. Wu, Anna Saucier, Robert J. Soiffer, Vincent T. Ho
Publikováno v:
Blood Advances
Key Points With sufficient resources, HSCT can safely continue in the COVID-19 pandemic if primary responsibility for COVID-19 patients is not required. Cryopreservation of unrelated donor products correlated with slightly lower chimerism but no diff
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b77462da4eb245082f4300dce3259459
https://doi.org/10.1182/bloodadvances.2020003883
https://doi.org/10.1182/bloodadvances.2020003883
Autor:
Gary Simmons, Robert A. Redd, Kevin Tang, Mazyar Shadman, Jennifer L. Crombie, Caron A. Jacobson, Geoffrey Shouse, Victor A. Chow, Loretta J. Nastoupil, Omar Castaneda Puglianini, Anna Saucier, Alex F. Herrera, Philippe Armand
Publikováno v:
Blood Adv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::374e919bd5d67a9c514026ca4a0ede7b
https://doi.org/10.1182/bloodadvances.2021004880
https://doi.org/10.1182/bloodadvances.2021004880
Autor:
Ashley M. Nelson, P. Connor Johnson, Matthew J. Frigault, Alisha Yi, Carlisle E.W. Topping, Anna Saucier, Tejaswini Dhawale, Areej El-Jawahri, Caron A. Jacobson, Mitchell W. Lavoie, Mathew J Reynolds
Publikováno v:
Journal of the National Comprehensive Cancer Network : JNCCN. 19(8)
Background: CAR T-cell therapy has revolutionized the treatment of patients with hematologic malignancies, but it can result in prolonged hospitalizations and serious toxicities. However, data on the impact of CAR T-cell therapy on healthcare utiliza
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fabb2fabd4574228ba3920692db1cdae
https://pubmed.ncbi.nlm.nih.gov/33706257
https://pubmed.ncbi.nlm.nih.gov/33706257
Autor:
Robert J. Soiffer, Cindy Albert, Catherine J. Wu, Sarah Nikiforow, Haesook T. Kim, Vincent T. Ho, Corey Cutler, Utkarsh Acharya, Julie Porter, Anna Saucier, Katie Maurer, Clifton C. Mo, Caron A. Jacobson
Publikováno v:
Transplantation and Cellular Therapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b1f01d05cb5bb79b5320bffa316c2f56
https://doi.org/10.1016/s2666-6367(21)00450-4
https://doi.org/10.1016/s2666-6367(21)00450-4
Autor:
Brian T. Hess, Philippe Armand, Jonathon B. Cohen, Geoffrey Shouse, Jason T. Romancik, Roch Houot, Caron A. Jacobson, Victor A. Chow, Alex F. Herrera, Anna Saucier, Erin Mullane, Jennifer L. Crombie, Jordan Gauthier, Robert A. Redd
Publikováno v:
Blood. 138:886-886
Introduction: Although anti-CD19 autologous chimeric antigen receptor (CAR) T-cell therapy has transformed the management of relapsed/refractory non-Hodgkin lymphoma (NHL), the majority of patients will ultimately relapse. The prognostic implications
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5af50719b9084c94dc3e0dd3fb32788b
https://doi.org/10.1182/blood-2021-152819
https://doi.org/10.1182/blood-2021-152819
Autor:
Alexandra Waller, Boyu Hu, Caron A. Jacobson, Loretta J. Nastoupil, Lindsey Fitzgerald, Anna Saucier, Jonathan Chipman, Manali Kamdar, Adam Kittai, Nathan Denlinger, Janet Spradley
Publikováno v:
Journal of Clinical Oncology. 38:8039-8039
8039 Background: CAR-T has drastically improved outcomes for R/R DLBCL patients (pts). While CAR-T is now standard of care for the treatment of R/R DLBCL, little is known about its efficacy and toxicity in elderly pts. Methods: We conducted a multi-c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f8f97ce4009fcd82fe374003f860a1a9
https://doi.org/10.1200/jco.2020.38.15_suppl.8039
https://doi.org/10.1200/jco.2020.38.15_suppl.8039